AROA BIOSURGERY LIMITED Inactive Instrument
Aroa Biosurgery Limited Australian S.E.
Equities
ARX
AU0000094146
Medical Equipment, Supplies & Distribution
Presenter SpeechNeetha Alex-Kumar (Executives)Good morning. Welcome to Aroa Biosurgery's inves...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Aroa Biosurgery Limited is a soft-tissue regeneration company. It develops, manufactures, sells, and distributes medical and surgical products to improve healing in complex wounds and soft tissue reconstruction. Its products are developed from the AROA extracellular matrix (ECM) technology platform, an extracellular matrix biomaterial derived from ovine forestomach. AROA ECM is an ECM biomaterial containing a rich and complex mix of biological molecules that is the building block for a range of soft tissue repair products. Its products include Endoform, Myriad Matrix, Myriad Morcells, Myriad Morcells Fine, and Reinforced Bioscaffolds. Endoform products support all phases of wound healing and are appropriate for use early in wound management to restore protease balance and advance healing to the proliferative phase. Myriad Matrix is an engineered ECM for soft tissue repair, reinforcement and complex wounds. Its subsidiaries are Aroa Biosurgery Incorporated and Mesynthes Nominee Limited.
| 1st Jan change | Capi. | |
|---|---|---|
| +9.12% | 28.11B | |
| -35.22% | 3.03B | |
| -21.21% | 2.39B | |
| +5.74% | 2.18B | |
| -11.31% | 1.9B | |
| +21.11% | 1.88B | |
| +23.77% | 1.3B | |
| +13.02% | 1.23B | |
| -4.47% | 1.23B |
